Has Sead Beganovic, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,106 in general payments to Sead Beganovic, MD across 398 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sead Beganovic, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sead Beganovic, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sead Beganovic, MD

Medical Oncology · Indianapolis, INNPI 1821080847

Payments from drug & device makers

$7,106in general payments, 2019–2025

Across 398 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$704
Johnson & Johnson$629
Pfizer$568
Amgen$479
E.r. Squibb & Sons, L.L.C.$438
Astellas Pharma US Inc$437
plus $4K from 42 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	57	$704
Johnson & Johnson(2 entities)	30	$629
Pfizer	34	$568
Amgen	33	$479
E.r. Squibb & Sons, L.L.C.	27	$438
Astellas Pharma US Inc	23	$437
Gilead	20	$380
Sanofi	16	$341
Merck	15	$292
Bristol Myers Squibb	15	$282
Seagen Inc.	8	$280
AstraZeneca(2 entities)	10	$233
AbbVie	12	$219
Eisai Inc.	8	$148
Array Biopharma Inc	9	$143
Servier Pharmaceuticals LLC	7	$138
Daiichi Sankyo Inc.	6	$114
Pharmacosmos Therapeutics Inc.	5	$98
Ipsen Biopharmaceuticals, Inc	4	$85
Genentech USA, Inc.	5	$81
Incyte Corporation	3	$67
Sun Pharmaceutical Industries Inc.	3	$67
Takeda Pharmaceuticals U.S.A., Inc.	4	$64
GSK	4	$64
Genmab U.S., Inc.	3	$59
Adaptive Biotechnologies Corporation	2	$57
Tersera Therapeutics LLC	2	$56
Mirati Therapeutics, Inc.	2	$52
Jazz Pharmaceuticals Inc.	3	$50
Sobi, Inc	3	$47
EMD Serono, Inc.	2	$38
Pharmaessentia USA Corporation	2	$38
Kyowa Kirin, Inc.	2	$34
Acrotech Biopharma Inc.	2	$32
Pharmacyclics LLC, An Abbvie Company	2	$31
Legend Biotech USA Inc.	2	$31
Helsinn Therapeutics (U.S.), Inc.	2	$26
CTI Biopharma Corp.	1	$23
Deciphera Pharmaceuticals Inc.	1	$22
AVEO Pharmaceuticals, Inc.	1	$20
Accord Healthcare, Inc.	1	$20
Lilly USA, LLC	1	$18
Recordati_rare_diseases_inc.	1	$18
Rigel Pharmaceuticals, Inc.	1	$17
ADC Therapeutics America, Inc.	1	$17
Boehringer Ingelheim	1	$17
Bayer	1	$16
Foundation Medicine, Inc.	1	$14

How this compares

$7,106 in reported general payments places this provider in the 40th percentile of 67 medical oncology providers in Indiana.

See all medical oncology providers in Indiana →

Medicare billing

Part B allowed, 2024

$89,414

Medicare patients

177

Services billed

1,228

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Indianapolis

Bert OneilIndianapolis$7.6M
Natraj AmmakkanavarIndianapolis$4.1M
Nasser HannaIndianapolis$2M
Pablo BedanoIndianapolis$886K
Kelvin LeeIndianapolis$662K
Nikhil ShuklaIndianapolis$627K
Mary MayerIndianapolis$310K
Daniel SonnenburgIndianapolis$184K
Shiroo ParshadIndianapolis$166K
Ashwin VasudevamurthyIndianapolis$157K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →